[1]
|
Fehr, A.R. and Perlman, S. (2015) Coronaviruses: An Overview of Their Replication and Pathogenesis. In: Maier, H., Bickerton, E. and Britton, P., Eds., Coronaviruses, Vol. 1282, Humana Press, New York, 1-23.
https://doi.org/10.1007/978-1-4939-2438-7_1
|
[2]
|
Li, F. (2016) Structure, Function, and Evolution of Coronavirus Spike Proteins. Annual Review of Virology, 3, 237-261.
https://doi.org/10.1146/annurev-virology-110615-042301
|
[3]
|
Corman, V.M., Eckerle, I., Memish, Z.A., Liljander, A.M., Dijkman, R., Jonsdottir, H., et al. (2016) Link of a Ubiquitous Human Coronavirus to Dromedary Camels. Proceedings of the National Academy of Sciences of the United States of America, 113, 9864-9869. https://doi.org/10.1073/pnas.1604472113
|
[4]
|
Xu, J., Zhao, S., Teng, T., Abdalla, A.E., Zhu, W., Xie, L., et al. (2020) Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses, 12, Article No. 244.
https://doi.org/10.3390/v12020244
|
[5]
|
WHO (2020) COVID-19 Weekly Epidemiological Update—6 April 2021.
https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---6-april-2021
|
[6]
|
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., et al. (2020) Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study. Lancet, 395, 1054-1062.
https://doi.org/10.1016/S0140-6736(20)30566-3
|
[7]
|
Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., et al. (2020) Kidney Disease Is Associated with In-Hospital Death of Patients with COVID-19. Kidney International, 97, 829-838.
https://doi.org/10.1016/j.kint.2020.03.005
|
[8]
|
Richardson, S., Hirsch, J.S., Narasimhan, M., Crawford, J.M., McGinn, T., Davidson, K.W., et al. (2020) Presenting Characteristics, Comorbidities, and Outcomes among 5700 Patients Hospitalized with COVID-19 in the New York City Area. JAMA, 323, 2052-2059. https://doi.org/10.1001/jama.2020.6775
|
[9]
|
Gabarre, P., Dumas, G., Dupont, T., Darmon, M., Azoulay, E. and Zafrani, L. (2020) Acute Kidney Injury in Critically Ill Patients with COVID-19. Intensive Care Medicine, 46, 1339-1348. https://doi.org/10.1007/s00134-020-06153-9
|
[10]
|
Chen, R., Liang, W., Jiang, M., Guan, W., Zhan, C., Wang, T., et al. (2020) Risk Factors of Fatal Outcome in Hospitalized Subjects with Coronavirus Disease 2019 from a Nationwide Analysis in China. Chest, 158, 97-105.
https://doi.org/10.1016/j.chest.2020.04.010
|
[11]
|
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., et al. (2020) A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine, 382, 727-733. https://doi.org/10.1056/NEJMoa2001017
|
[12]
|
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., et al. (2020) Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. New England Journal of Medicine, 382, 1199-1207.
https://doi.org/10.1056/NEJMoa2001316
|
[13]
|
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., et al. (2020) A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin. Nature, 579, 270-273. https://doi.org/10.1038/s41586-020-2012-7
|
[14]
|
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., et al. (2020) Genomic Characterisation and Epidemiology of 2019 Novel Coronavirus: Implications for Virus Origins and Receptor Binding. Lancet, 395, 565-574.
https://doi.org/10.1016/S0140-6736(20)30251-8
|
[15]
|
Ji, W., Wang, W., Zhao, X., Zai, J. and Li, X. (2020) Cross-Species Transmission of the Newly Identified Coronavirus 2019-nCoV. Journal of Medical Virology, 92, 433-440. https://doi.org/10.1002/jmv.25682
|
[16]
|
Xu, X., Chen, P., Wang, J., Feng, J., Zhou, H., Li, X., et al. (2020) Evolution of the Novel Coronavirus from the Ongoing Wuhan Outbreak and Modeling of Its Spike Protein for Risk of Human Transmission. Science China Life Sciences, 63, 457-460. https://doi.org/10.1007/s11427-020-1637-5
|
[17]
|
Chan, J.F.-W., Kok, K.-H., Zhu, Z., Chu, H., To, K.K.-W., Yuan, S., et al. (2020) Genomic Characterization of the 2019 Novel Human-Pathogenic Coronavirus Isolated from a Patient with Atypical Pneumonia after Visiting Wuhan. Emerging Microbes & Infections, 9, 221-236. https://doi.org/10.1080/22221751.2020.1719902
|
[18]
|
Liu, Z., Xiao, X., Wei, X., Li, J., Yang, J., Tan, H., et al. (2020) Composition and Divergence of Coronavirus Spike Proteins and Host ACE2 Receptors Predict Potential Intermediate Hosts of SARS-CoV-2. Journal of Medical Virology, 92, 595-601. https://doi.org/10.1002/jmv.25726
|
[19]
|
Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y. and Zhou, Q. (2020) Structural Basis for the Recognition of SARS-CoV-2 by Full-Length Human ACE2. Science, 367, 1444-1448. https://doi.org/10.1126/science.abb2762
|
[20]
|
Wan, Y., Shang, J., Graham, R., Baric, R.S. and Li, F. (2020) Receptor Recognition by the Novel Coronavirus from Wuhan: An Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. Journal of Virology, 94, e00127-20.
https://doi.org/10.1128/JVI.00127-20
|
[21]
|
Wrapp, D., Wang, N., Corbett, K.S., Goldsmith, J.A., Hsieh, C.-L., Abiona, O., et al. (2020) Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation. Science, 367, 1260-1263. https://doi.org/10.1126/science.abb2507
|
[22]
|
Zou, X., Chen, K., Zou, J., Han, P., Hao, J. and Han, Z. (2020) Single-Cell RNA-Seqdata Analysis on the Receptor ACE2 Expression Reveals the Potential Risk of Different Human Organs Vulnerable to 2019-nCoV Infection. Frontiers of Medicine, 14, 185-192. https://doi.org/10.1007/s11684-020-0754-0
|
[23]
|
张明鑫, 路宁, 王佳, 朱琳, 崔曼莉. 新型冠状病毒细胞受体血管紧张素转化酶II在消化道及其肿瘤中的表达[J]. 现代肿瘤医学, 2020, 28(7): 1229-1233.
|
[24]
|
Chen, Y., Guo, Y., Pan, Y. and Zhao, Z.J. (2020) Structure Analysis of the Receptor Binding of 2019-nCoV. Biochemical and Biophysical Research Communications, 525, 135-140. https://doi.org/10.1016/j.bbrc.2020.02.071
|
[25]
|
Vieira Braga, F.A., Kar, G., Berg, M., Carpaij, O.A., Polanski, K., Simon, L.M., et al. (2019) A Cellular Census of Human Lungs Identifies Novel Cell States in Health and in Asthma. Nature Medicine, 25, 1153-1163.
https://doi.org/10.1038/s41591-019-0468-5
|
[26]
|
Deng, Y.Y., Zheng, Y., Cai, G.Y., Chen, X.M. and Hong, Q. (2020) Single-Cell RNA Sequencing Data Suggest a Role for Angiotensin-Converting Enzyme 2 in Kidney Impairment in Patients Infected with 2019-nCoV. Chinese Medical Journal, 133, 1129-1131. https://doi.org/10.1097/CM9.0000000000000783
|
[27]
|
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al. (2020) Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. Lancet, 395, 497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
|
[28]
|
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., et al. (2020) Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine, 382, 1708-1720.
https://doi.org/10.1101/2020.02.06.20020974
|
[29]
|
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., et al. (2020) Clinical Characteristics of 113 Deceased Patients with Coronavirus Disease 2019: Retrospective Study. BMJ, 368, m1091. https://doi.org/10.1136/bmj.m1091
|
[30]
|
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., et al. (2020) Clinical Course and Outcomes of Critically Ill Patients with SARS-CoV-2 Pneumonia in Wuhan, China: A Single-Centered, Retrospective, Observational Study. The Lancet Respiratory Medicine, 8, 475-481. https://doi.org/10.1016/S2213-2600(20)30079-5
|
[31]
|
Ye, M., Wysocki, J., William, J., Soler, M.J., Cokic, I. and Batlle, D. (2006) Glomerular Localization and Expression of Angiotensin-Converting Enzyme 2 and Angiotensin-Converting Enzyme: Implications for Albuminuria in Diabetes. Journal of the American Society of Nephrology, 17, 3067-3075. https://doi.org/10.1681/ASN.2006050423
|
[32]
|
Su, H., Yang, M., Wan, C., Yi, L.X., Tang, F., Zhu, H.Y., et al. (2020) Renal Histopathological Analysis of 26 Postmortem Findings of Patients with COVID-19 in China. Kidney International, 98, 219-227.
https://doi.org/10.1016/j.kint.2020.04.003
|
[33]
|
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., et al. (2020) Pathological Findings of COVID-19 Associated with Acute Respiratory Distress Syndrome. The Lancet Respiratory Medicine, 8, 420-422.
https://doi.org/10.1016/S2213-2600(20)30076-X
|
[34]
|
Bellomo, R., Kellum, J.A., Ronco, C., Wald, R., Martensson, J., Maiden, M., et al. (2017) Acute Kidney Injury in Sepsis. Intensive Care Medicine, 43, 816-828. https://doi.org/10.1007/s00134-017-4755-7
|
[35]
|
Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., et al. (2020) Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA, 323, 1574-1581. https://doi.org/10.1001/jama.2020.5394
|
[36]
|
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., et al. (2020) Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Internal Medicine, 180, 934-943. https://doi.org/10.1001/jamainternmed.2020.0994
|
[37]
|
Holshue, M.L., DeBolt, C., Lindquist, S., Lofy, K.H., Wiesman, J., Bruce, H., et al. (2020) First Case of 2019 Novel Coronavirus in the United States. New England Journal of Medicine, 382, 929-936.
https://doi.org/10.1056/NEJMoa2001191
|
[38]
|
Grein, J., Ohmagari, N., Shin, D., Diaz, G., Asperges, E., Castagna, A., et al. (2020) Compassionate Use of Remdesivir for Patients with Severe Covid-19. New England Journal of Medicine, 382, 2327-2236.
https://doi.org/10.1056/NEJMoa2007016
|
[39]
|
Savarino, A., Boelaert, J.R., Cassone, A., Majori, G. and Cauda, R. (2003) Effects of Chloroquine on Viral Infections: An Old Drug against Today’s Diseases? The Lancet Infectious Diseases, 3, 722-727.
https://doi.org/10.1016/S1473-3099(03)00806-5
|
[40]
|
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., et al. (2020) Remdesivir and Chloroquine Effectively Inhibit the Recently Emerged Novel Coronavirus (2019-nCoV) in Vitro. Cell Research, 30, 269-271.
https://doi.org/10.1038/s41422-020-0282-0
|
[41]
|
Gao, J., Tian, Z. and Yang, X. (2020) Breakthrough: Chloroquine Phosphate Has Shown Apparent Efficacy in Treatment of COVID-19 Associated Pneumonia in Clinical Studies. Bioscience Trends, 14, 72-73.
|
[42]
|
Shen, C., Wang, Z., Zhao, F., Yang, Y., Li, J., Yuan, J., et al. (2020) Treatment of 5 Critically Ill Patients with COVID-19 with Convalescent Plasma. JAMA, 323, 1582-1589. https://doi.org/10.1001/jama.2020.4783
|
[43]
|
Liu, X., Liu, C., Liu, G., Luo, W. and Xia, N. (2020) COVID-19: Progress in Diagnostics, Therapy and Vaccination. Theranostics, 10, 7821-7835. https://doi.org/10.7150/thno.47987
|
[44]
|
Zhang, Y., Zeng, G., Pan, H., Li, C., Hu, Y., Chu, K., et al. (2021) Safety, Tolerability, and Immunogenicity of an Inactivated SARS-CoV-2 Vaccine in Healthy Adults Aged 18-59 Years: A Randomised, Double-Blind, Placebo-Controlled, Phase 1/2 Clinical Trial. The Lancet Infectious Diseases, 21, 181-192. https://doi.org/10.1016/S1473-3099(20)30843-4
|
[45]
|
Zhu, F.C., Li, Y.H., Guan, X.H., Hou, L.H., Wang, W.J., Li, J.X., et al. (2020) Safety, Tolerability, and Immunogenicity of a Recombinant Adenovirus Type-5 Vectored COVID-19 Vaccine: A Dose-Escalation, Open-Label, Non-Randomised, First-in-Human Trial. Lancet, 395, 1845-1854. https://doi.org/10.1016/S0140-6736(20)31208-3
|
[46]
|
Zhu, F.C., Guan, X.H., Li, Y.H., Huang, J.Y., Jiang, T., Hou, L.H., et al. (2020) Immunogenicity and Safety of a Recombinant Adenovirus Type-5-Vectored COVID-19 Vaccine in Healthy Adults Aged 18 Years or Older: A Randomised, Double-Blind, Placebo-Controlled, Phase 2 Trial. Lancet, 396, 479-488.
https://doi.org/10.1016/S0140-6736(20)31605-6
|